JH-VIII-157-02
CAS No. 1639422-97-1
JH-VIII-157-02 ( JH-VIII-157-02; JH-VIII-15702; JH-VIII-157 02; JHVIII-157-02 )
产品货号. M12480 CAS No. 1639422-97-1
JH-VIII-157-02 is a potent, orally active, CNS-permeable, second-generation inhibitor of ALK G1202R mutant with IC50 of 2 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3418 | 有现货 |
|
10MG | ¥5087 | 有现货 |
|
25MG | ¥7946 | 有现货 |
|
50MG | ¥10935 | 有现货 |
|
100MG | ¥14742 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称JH-VIII-157-02
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述JH-VIII-157-02 is a potent, orally active, CNS-permeable, second-generation inhibitor of ALK G1202R mutant with IC50 of 2 nM.
-
产品描述JH-VIII-157-02 is a potent, orally active, CNS-permeable, second-generation inhibitor of ALK G1202R mutant with IC50 of 2 nM, also shows high potency against a variety of other frequently observed mutants (G1269A, S1206Y, F1174L and C1156Y); inhibits EML4-ALKWT with IC50 of 2 nM, demonstrates inhibition of CSNK2A1 <10 uM, IRAK1 (IC50 =14 nM), IRAK4 with (IC50=465 nM), CLK4 (IC50=14 nM), RET (IC50=3 nM), RET V804L (IC50=13 nM); potently inhibits proliferation of NSCLC H3122 cell line with IC50 of 5 nM.
-
同义词JH-VIII-157-02; JH-VIII-15702; JH-VIII-157 02; JHVIII-157-02
-
通路Angiogenesis
-
靶点ALK
-
受体ALK
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1639422-97-1
-
分子量465.56
-
分子式C28H27N5O2
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 25 mg/mL 53.70 mM
-
SMILESO=C(N(C)C)CN1N=CC(C2=C(CC)C=C3C(C(C)(C)C(NC4=C5C=CC(C#N)=C4)=C5C3=O)=C2)=C1
-
化学全称2-(4-(3-cyano-9-ethyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazol-8-yl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hatcher JM, et al. J Med Chem. 2015 Dec 10;58(23):9296-9308.
2. Wang H, et al. Drug Des Devel Ther. 2018 May 9;12:1183-1193.
2. Wang H, et al. Drug Des Devel Ther. 2018 May 9;12:1183-1193.
产品手册
关联产品
-
CEP-28122
A highly potent and selective, orally active ALK inhibitor with IC50 of 1.9 nM.
-
JH-VIII-157-02
JH-VIII-157-02 is a potent, orally active, CNS-permeable, second-generation inhibitor of ALK G1202R mutant with IC50 of 2 nM.
-
LDN193189
LDN193189 is a potent, selective BMP type I receptor that inhibits BMP4-induced phosphorylation of SMAD1/5/8 with IC50 of 5 nM.